1H MR spectroscopy of the brain in HIV-1-seropositive subjects: Evidence for diffuse metabolic abnormalities

Metabolic Brain Disease

Volumn 13, Issue 2, 1998, Pages 123-136

  Marcus, Claude D ^a,d   Taylor Robinson, Simon D ^a   Sargentoni, Janet ^a   Ainsworth, Jonathan G ^b   Frize, Graeme ^b   Easterbrook, Philippa J ^c   Shaunak, Sunil ^a   Bryant, David J ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b ST MARY S HOSPITAL   (United Kingdom)

^c CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

^d SERVICE DE DERMATOLOGIE   (France)

Author keywords

Acquired immunodeficiency syndrome (AIDS); Brain; HIV 1 associated dementia; Magnetic resonance (MR) spectroscopy

Indexed keywords

CHOLINE; CREATINE; N ACETYLASPARTIC ACID; ZIDOVUDINE;

ADULT; ARTICLE; BRAIN METABOLISM; CLINICAL ARTICLE; CONTROLLED STUDY; DEMENTIA; FRONTAL LOBE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; METABOLITE; NEUROPSYCHIATRY; PARIETAL LOBE; PROTON NUCLEAR MAGNETIC RESONANCE; WHITE MATTER; ACQUIRED IMMUNE DEFICIENCY SYNDROME; BRAIN; IMMUNOLOGY; METABOLISM; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY;

ADULT; AIDS DEMENTIA COMPLEX; BRAIN; HIV SEROPOSITIVITY; HIV-1; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED;

EID: 0031596344     PISSN: 08857490     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1020609213664     Document Type: Article

References (46)

1. Aronow, H.A., Brew, B.J., and Price, R.W. (1988). The management of the neurological complications of HIV infection and AIDS. AIDS 2:5151-5159.
2. Aylward, E.H., Henderer, J.D., McArthur, J.C., et al. (1993). Reduced basal ganglia volume in HIV-1 associated dementia : results from quantitative neuroimaging. Neurology 43:2099-2104.
3. Barker, P.B., Lee, R.R., and McArthur, J.C. (1995). AIDS dementia complex : evaluation with proton MR spectroscopic imaging. Radiology 195:58-64.
4. Budka, H., Wiley, C.A., Kleihues, P., et al. (1991). HIV-associated disease of the nervous system: review of nomenclature and proposal for neuropathology-based terminology. Brain Pathol. 1:143-152.
5. Budka, H. (1991). Neuropathology of human immunodeficiency virus infection. Brain Pathol. 1:163-175.
6. Bottomley, P.A., Hardy, C.J., Cousins, J.P., Armstrong, M., and Wagle WA. (1990). AIDS dementia complex : brain high-energy phosphate metabolite deficits. Radiology 176:407-411.
7. Bryant, D.J., Weeks, R.A., Marcus, C.D., Sargentoni, J., Taylor-Robinson, S., and Brooks, D.J. (1994). Glutamate in Huntington's disease. (Authors' reply) Lancet 344:189-190.
8. Centers for Disease Control: revision of the CDC surveillance case definition for acquired immunodeficiency syndrome (1987). MMWR 36 (suppl 1S):S1-S15.
9. Chong, W.K., Sweeney, B., Wilkinson, I.D., et al. (1993). Proton spectroscopy of the brain in HIV infection : correlation with clinical, immunologic, and MR imaging findings. Radiology 188:119-124.
10. Chong, W.K., Paley, M., Wilkinson, I.D., et al. (1994). Localized cerebral proton MR spectroscopy in HIV infection and AIDS. AJNR 15:21-25.
11. 31P Magnetic Resonance spectroscopy of the normal human brain: Approaches using four-dimensional chemical imaging and phase mapping techniques. NMR Biomed. 4:190-197
12. Donovan Post, M.J., Berger, J.R., and Quencer, R.M. (1991). Asymptomatic and neurologically symptomatic HIV-seropositive individuals: prospective evaluation with cranial MR imaging. Radiology 178:131-139.
13. Donovan Post, M.J., Berger, J.R., Duncan, R., Quencer, R.M., Pall, L., and Winfield, D. (1993). Asymptomatic and neurologically symptomatic HIV-seropositive subjects: results of long-term MR imaging and clinical follow-up. Radiology 188:727-733.
14. Everall, I.P., Luthert, P.J., and Lantos, P.L. (1991). Neuronal loss in the frontal cortex in HIV infection. Lancet 337:1119-1121.
15. Everall, I.P., Luthert, P.J., and Lantos, P.L. (1993). Neuronal number and volume alterations in the neocortex of HIV infected individuals. J. Neurol. Neurosurg. Psychiatry 56:481-486.
16. Glass, J.D., Wesselingh, S.L., Seines, O.A., and McArthur, J.C. (1993). Clinical-neuropathologic correlation in HIV-associated dementia. Neurology 43:2230-2237.
17. Hawkins, C.P., McLaughlin, J.E., Kendall, B.E., and McDonald, W.I. (1993). Pathological findings correlated with MRI in HIV infection. Neuroradiology 35:264-268.
18. Hinkin, C.H., Van Gorp, W.G., Mandelkern, M.A., et al. (1995). Cerebral metabolic change in patients with AIDS : report of a six-month follow-up using positron-emission tomography. J. Neuropsychiatr, Clin. Neurosci. 7:180-187
19. Jarvik, J.G., Lenkinski, R.E., Grossman, R.I., Gomori, J.M., Schnall, M.D., and Frank, I. (1993). Proton MR spectroscopy of HIV-infected patients: characterization of abnormalities with imaging and clinical correlation. Radiology 186:739-744.
20. Karlsen, N.R, Reinvang I, and Froland, S.S. (1993). A follow-up study of neuropsychological function in asymptomatic HIV-infected patient. Acta Neurol. Scand. 87:83-87.
21. Ketzler, S., Weis, S., Haug, H., and Budka, H. (1990). Loss of neurons in the frontal cortex in AIDS brains. Acta Neuropathol. 80:92-94.
22. Kreis, R., Farrow, N., and Ross, B.D. (1993). Absolute quantitation of water and metabolites in the brain. Metabolite concentrations. J. Magn. Reson. 102:9-19.
23. Laubenberger, J., Häussinger, D., Bayer, S., Thielemann, S., Schneider, B., Mundinger, A., Hennig, J., and Langer, M. (1996). HIV-related metabolic abnormalities in the brain: depiction with proton MR spectroscopy with short echo times. Radiology 199:805-810.
24. Lenkinski, R.E., Frank, I., and Saykin, A. (1995). Proton MR studies of HIV seropositive asymptomatic patients. 3D Scientific Meeting of the Society for Magnetic Resonance, Nice, [abstract 3:1798].
25. Mauri, M., Sinforiani, E., Muratori, S., Zerboni, R., and Bono, G. (1993). Three year neuropsychological follow-up in a selected group of HIV-infected homosexual/bisexual men. AIDS 7:241-245.
26. McBean, G.J., and Robert, P.J. (1984). Chronic infusion of L-Glutamate causes neurotoxicity in the rat striatum. Brain Res. 290:372-375.
27. McConnell, J.R., Swindelles, S., Ong. C.S., et al. (1994). Prospective utility of cerebral proton magnetic resonance spectroscopy in monitoring HIV infection and its associated neurological impairment. AIDS Res. Hum. Retroviruses 10:977-982.
28. Menon, D.K., Baudouin, C.J., Tomlinson, D., and Hoyle, C. (1990). Proton MR spectroscopy and imaging of the brain in AIDS: evidence of neuronal loss in regions that appear normal with imaging. J. Comput. Assist. Tomogr. 14:882-885.
29. Menon, K., Ainsworth, J.G., Cox, I.J., et al. (1992). Proton MR spectroscopy of the brain in AIDS dementia complex. J. Comput. Assist. Tomogr. 16:538-542.
30. 1H magnetic resonance spectroscopic imaging. Neurology. 43:509-515.
31. Miller, B.L., Moats, R.A., Shonk, T., et al. (1993). Alzheimer disease: depiction of increased cerebral myoinositol with proton MR spectroscopy. Radiology 187:433-437.
32. Navia, B.A., Cho, E.S., Petito, C.K., Price, R.W. (1986). The AIDS dementia complex : II Neuropathology. Ann. Neurol. 19:525-535.
33. Olsen, W.L., Longo, F.M., Mills, C.M., and Norman, D. (1988). White matter disease in AIDS: findings at MR imaging. Radiology 169:445-448.
34. Portegies, P., Enting, R.H., de Gans, J., et al. (1993). Presentation and course of AIDS dementia complex: 10 years of follow-up in Amsterdam, the Netherlands. AIDS 7:669-679.
35. Saeed, N., and Menon, D.K. (1993). A knowledge-based approach to minimize baseline roll in chemical shift imaging. Magn. Reson. Med. 29:591-598.
36. Schmidbauer, M., Huemer, M., Cristina, S., Trabattoni, G.R., and Budka, H. (1992). Morphological distribution and clinical correlation of white matter lesions in AIDS brains. Neuropathol. 18:489-501.
37. Seilhean, D., Duyckaerts, C., Vazeux, R., et al. (1993). HIV-1-associated cognitive/motor complex: absence of neuronal loss in the cerebral neocortex. Neurology 43:1492-1499.
38. Shiino, A., Matsuda, M., Morikawa, S., Inubushi, T., Akiguchi, I., and Handa, J. (1993). Proton magnetic resonance spectroscopy with dementia. Surg. Neurol. 39:143-147.
39. Taylor-Robinson, S.D., Sargentoni, J., Marcus, C.D., Morgan, M.Y., and Bryant. D.J. (1994a). Regional variations in cerebral proton spectroscopy in patients with chronic hepatic encephalopathy. Metab. Brain Dis. 9:347-359.
40. Taylor-Robinson, S.D., Weeks, R.A., Sargentoni, J., et al. (1994b). Evidence for glutamate excitotoxicity in Huntingdon's disease using proton magnetic resonance spectroscopy. Lancet 343:1170.
41. Taylor-Robinson, S.D., Weeks, R.A., Bryant, D.J., et al (1996). Proton MRS in Huntington's disease: evidence in favour of glutamate excitotoxic theory? Movement Disord. 11:167-173.
42. Tracey, I., Carr, C.A., Guimaraes, A.R., Worth, J.L., Navia, B.A., and Gonzalez, R.G. (1996). Brain choline-containing compounds are elevated in HIV-positive patients before the onset of AIDS dementia complex: a proton magnetic resonance spectroscopic study. Neurology 46:783-788.
43. van Gorp, W.G., Mandelkern, M.A., Gee, M., et al. (1992). Cerebral metabolic dysfunction in AIDS : findings in a sample with and without dementia. J. Neuropsychiatry Clin. Neurosci. 4:280-287.
44. van Gorp, W.G., Miller, E.N., Marcotte, T.D., et al. (1994). The relationship between age and cognitive impairment in HIV-1 infection: findings from the multicenter AIDS cohort study and a clinical cohort. Neurology 44:929-935.
45. Vion-Dury, J., Confort-Gouny, S., Nicoli, F., et al.(1994). Localized brain proton MRS metabolic patterns in HIV-related encephalopathies. C.R. Acad. Sci. III. 317:833-840.
46. Vion-Dury, J., Nicoli, F., Salvan, A.M., Confort-Gouny, S., Dhiver, C., and Cozzone, P.J.(1995). Reversal of brain metabolic alterations with zidovudine detected by proton localised magnetic resonance spectroscopy. Lancet 345:60-61.